UnitedHealth Group (UHG) has been overcharging some cancer patients by more than 1,000 percent for live-changing drugs, a damning new report has revealed.

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC) accused their pharmacy benefit manager units of imposing significant price markups on specialty ...

(Bloomberg) -- Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly ... than $7.3 billion in “excess” revenue over six years, the Federal Trade Commission said in a ...

The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...

FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

Here is a hard truth for those of us who are care providers: Americans are unsatisfied with the country's healthcare system.

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...

This page features the latest news about the UnitedHealth Group stock. FTC accuses CVS, Cigna, UnitedHealth of abusing middleman role, shares down Investing.com -- Shares of CVS Health Corp (NYSE ...

Your medical data is not as safe as you think. Discover how a massive ransomware attack exposed millions and the key steps to ...